Image of hexagons overlapping in different sizes

Broadening Narsoplimab Development from Orphan Indication to COVID-19 Treatment: CMC Regulatory Considerations

Home / Resource
Image with text 'WCBP'

Speaker Presentation Harris Jonathan, Omeros Corporation, 2021
Broadening Narsoplimab Development from Orphan Indication to COVID-19 Treatment: CMC Regulatory Considerations